A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk
Authors
Keywords
Breast cancer, Cancer prevention, Cancer risk reduction, BRCA1/2, Lovastatin, Clinical trial, Biomarkers, Random periareolar fine needle aspiration
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 142, Issue 2, Pages 389-398
Publisher
Springer Nature
Online
2013-10-28
DOI
10.1007/s10549-013-2739-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trials and Tribulations of Interrogating Biomarkers to Define Efficacy of Cancer Risk Reductive Interventions
- (2013) D. E. Brenner et al. Cancer Prevention Research
- A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer
- (2011) Michaela J. Higgins et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic
- (2011) F. L. Meyskens et al. Cancer Prevention Research
- Preventive therapy for breast cancer: a consensus statement
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Exemestane for Breast-Cancer Prevention in Postmenopausal Women
- (2011) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women
- (2010) E. A. Waters et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Lipophilic Statin Use and Risk of Breast Cancer Subtypes
- (2010) S. Woditschka et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer
- (2010) S. M. Lipkin et al. Cancer Prevention Research
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
- (2010) LANCET ONCOLOGY
- Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
- (2009) Elisabeth R. Garwood et al. BREAST CANCER RESEARCH AND TREATMENT
- Second Primary Breast Cancer Occurrence According to Hormone Receptor Status
- (2009) A. W. Kurian et al. JNCI-Journal of the National Cancer Institute
- Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
- (2008) Katriina Heikkilä et al. CANCER CAUSES & CONTROL
- An Automated Approach for Estimation of Breast Density
- (2008) J. J. Heine et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Estrogen Receptor-Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users
- (2008) A. S. Kumar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Statins and cancer: A systematic review and meta-analysis
- (2008) Jaana Kuoppala et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now